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Common diseases including cancer, cardiovascular disor-ders, chronic inflammatory diseases, and retinopathies are 
associated with pathological and ectopic vessel growth (neo-
vascularization), which in most cases implies a switch to more 
advanced disease stages associated with poor prognosis.1 For 
example, the growth of primary or metastatic tumor nodules 
to clinically detectable masses,2 growth and destabilization 
of atherosclerotic plaques before rupture,3 synovitis and joint 
hypertrophy in rheumatoid arthritis,4 macular edema, retinal 
detachment and vision loss in diabetic retinopathy (DR),5 and 
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Objective—Pathological neovascularization is crucial for progression and morbidity of serious diseases such as cancer, diabetic 
retinopathy, and age-related macular degeneration. While mechanisms of ongoing pathological neovascularization have 
been extensively studied, the initiating pathological vascular remodeling (PVR) events, which precede neovascularization 
remains poorly understood. Here, we identify novel molecular and cellular mechanisms of preneovascular PVR, by using 
the adult choriocapillaris as a model.
Approach and Results—Using hypoxia or forced overexpression of VEGF (vascular endothelial growth factor) in the subretinal 
space to induce PVR in zebrafish and rats respectively, and by analyzing choriocapillaris membranes adjacent to choroidal 
neovascular lesions from age-related macular degeneration patients, we show that the choriocapillaris undergo robust induction 
of vascular intussusception and permeability at preneovascular stages of PVR. This PVR response included endothelial 
cell proliferation, formation of endothelial luminal processes, extensive vesiculation and thickening of the endothelium, 
degradation of collagen fibers, and splitting of existing extravascular columns. RNA-sequencing established a role for 
endothelial tight junction disruption, cytoskeletal remodeling, vesicle- and cilium biogenesis in this process. Mechanistically, 
using genetic gain- and loss-of-function zebrafish models and analysis of primary human choriocapillaris endothelial cells, 
we determined that HIF (hypoxia-induced factor)-1α-VEGF-A-VEGFR2 signaling was important for hypoxia-induced PVR.
Conclusions—Our findings reveal that PVR involving intussusception and splitting of extravascular columns, endothelial 
proliferation, vesiculation, fenestration, and thickening is induced before neovascularization, suggesting that identifying 
and targeting these processes may prevent development of advanced neovascular disease in the future.
Visual Overview—An online visual overview is available for this article.  (Arterioscler Thromb Vasc Biol. 2019;39:1402-
1418. DOI: 10.1161/ATVBAHA.118.312190.)
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age-related macular degeneration (AMD)6 all depend on path-
ological neovascularization. Ongoing neovascularization is 
associated with pathological vascular phenotypes including 
lack of arterial-venous differentiation, pericyte coverage, and 
endothelial tightness resulting in poor perfusion, high leak-
age and interstitial fluid pressure, and reduced drug delivery 
and efficacy in the affected tissue.7,8 As such, targeting patho-
logical neovascularization has great potential for treatment of 
many common, serious diseases and is likely most effective if 
deployed early and preferably as a preventive strategy. While 
intensive research over the past several decades has led to tre-
mendous progress in our understanding of the mechanisms 
and processes involved in ongoing pathological neovascular-
ization,2 the molecular mechanisms involved in the initiating 
events, that is, early pathological vascular remodeling (PVR), 
remains underinvestigated and poorly understood. As such, 
there are currently no specific targets known, or treatments 
available, for preventing the switch from a pathologically 
activated vasculature to neovascularization. Furthermore, 
the cellular and physiological changes involved during pre-
neovascular activation are not known, preventing early diag-
nosis of patients at high risk of progression to neovascular 
disease stages.
The choriocapillaris is the vasculature located posterior 
to and closely associated with the retinal pigment epithelium 
(RPE) and photoreceptors of the outer retina. Choriocapillaris 
growth through the protective RPE-shield known as Bruch’s 
membrane, a process referred to as choroidal neovasculariza-
tion (CNV), causes the progression of AMD to advanced, so-
called exudative or wet, stages.9 As AMD is one of the most 
prevalent neovascularization-associated diseases and the most 
common cause of blindness worldwide, massive efforts have 
been dedicated to developing antineovascular treatments for 
this disorder. As a result, antineovascular drugs including 
bevacizumab, ranibizumab, and aflibercept, have been devel-
oped, which are effectively restoring vision in the short term 
for many wet AMD patients.10 However, once choriocapil-
laris have penetrated Bruch’s membrane and grown into the 
retina, which is the clinical indication for starting antineovas-
cular drug treatment, it is no longer possible to achieve full 
and persistent regression of pathological blood vessels. As the 
ectopic, subretinal vasculature that remains in patients after 
antineovascular treatment are thought to be involved in re-
currence, patients that have already developed wet AMD are 
at risk of progressing after a period of therapeutic benefit.9 
Similar problems are observed in other neovascularization-
associated diseases including DR, other chronic inflammatory 
disorders, and various types of cancer currently treated with 
antineovascular drugs.11,12 As such, identifying early, action-
able targets for pathological transformation of the involved 
vasculatures preceding neovascularization would potentially 
enable preventive rather than therapeutic measures to reduce 
the risk of disease progression and morbidity.
Intussusception is a form of vascular remodeling and 
growth involving the splitting of vessels by extending cellular 
processes generated by endothelial and vascular mural cells, 
into the vascular lumen.13 As these processes anastomose, they 
form transluminal, intussusceptive pillars (ISPs) that then ex-
pand by growing in circumference, fusing with other ISPs 
and remodel into extravascular columns of interstitial tissue. 
Eventually, this leads to the original vessel having transformed 
into vascular loops14 or by longitudinal intussusception into 2 
separate vessels.13 The developing choriocapillaris, lung, and 
kidney vasculatures, as well as pathological growth of ves-
sels in tumors and the cornea, are thought to use intussuscep-
tion as a mechanism of vascular growth and remodeling.14–17 
In these cases, intussusception is considered an alternative to 
sprouting angiogenesis17 or to mediate vascular maturation 
and remodeling following a period of ongoing angiogenesis.14 
Postneovascular intussusception might be used as a mech-
anism of evading antineovascular therapies, as vessels under-
going intussusception are stabilized and better able to resist 
for example anti-VEGF (vascular endothelial growth factor) 
drugs.14,18,19 As such it has been suggested that in the context 
of high levels of VEGF-signaling, vessels use sprouting angi-
ogenesis as their mechanism of growth, whereas in the con-
text of reduced or inhibited VEGF-signaling they switch to 
intussusception.17,19,20 Intussusception may, however, also be 
induced by VEGF-signaling,21 implying that the role of VEGF 
in regulating vessel sprouting versus intussusception is still 
incompletely understood and may be context-dependent.
Hypoxia is a main pathological driver of neovasculariza-
tion in disease.22,23 In hypoxic tissues, the catalytic activity of 
the oxygen sensors prolyl hydroxylase domain (PHD)-1–3 
and factor inhibiting HIF (hypoxia-induced factor; FIH) are 
reduced leading to impaired hydroxylation of HIFs resulting 
in their stabilization and unabated transcriptional activity.24 
Several vascular growth factors including VEGF are under 
control of HIFs and therefore increased in response to hy-
poxia.22 VEGF, in turn, activate signaling through type 1 ty-
rosine kinase receptors, primarily VEGF receptor-2 expressed 
by endothelial cells (ECs), leading to vascular leakage and 
growth.22,25 While HIF-1α is critical for acute responses to 
hypoxia, HIF-2α is important for responses to prolonged hy-
poxia26,27 and the transcriptomic changes induced by hypoxia 
Nonstandard Abbreviations and Acronyms
Acta2 α-smooth muscle actin
AMD age-related macular degeneration
CNV choroidal neovascularization
DR diabetic retinopathy
EC endothelial cell
ECM extracellular matrix
ELP endothelial luminal process
FACS fluorescence-activated cell sorting
HIF hypoxia-induced factor
hTBP human TATA box-binding protein
ISP intussusceptive pillar
PHD prolyl hydroxylase domain
PVR pathological vascular remodeling
RPE retinal pigment epithelium
SMC smooth muscle cell
TEM transmission electron microscopy
Tgn transgellin1
VEGF vascular endothelial growth factor
ZO zonula occludens
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and HIFs are highly context-dependent.28,29 While a number 
of sophisticated animal models have attempted to address 
the complex issue of hypoxia-induced pathological changes 
to blood vessels indirectly by for example increasing the ox-
ygen consumption in the RPE or reducing endothelial HIF-
1α–signaling,30–32 it has not been possible to directly induce 
and control tissue hypoxia per se, in rodents.
Zebrafish are highly amenable to hypoxia studies as they 
are naturally hypoxia-tolerant and survive in severely hypoxic 
conditions for prolonged periods of time.22,33–35 In addition, 
zebrafish respond to complex pathophysiological stimuli, in-
cluding hypoxia, in a manner that strongly resembles human 
disease. For example, human tumor cells implanted in zebrafish 
induce angiogenesis, disseminate and exhibit drug responses 
identical to those of the patient that donated the cells,36–38 and 
these processes are regulated by tumor hypoxia.22,39,40 In eye re-
search, zebrafish models are particularly interesting as diabetic 
zebrafish exhibit cone-degeneration and vascular changes in 
the retinal vasculature similar to early stages of DR41 and hy-
poxia treatment induces retinal neovascularization by sprouting 
of new retinal capillaries similar to what is seen in patients with 
late-stage, proliferative DR.34 Similarly, hypoxia treatment of 
adult zebrafish has been implicated in opening up lymphatic 
vessels for perfusion with blood as a mechanism of rapidly 
increasing blood delivery to the tissues.42 While the retinal vas-
culature and large choroidal vessels have been studied in zebraf-
ish,43–45 the choriocapillaris has, however, not been identified.
In this study, we identify and thoroughly characterize the 
adult zebrafish choriocapillaris and use this vasculature as a 
model for identifying a hypoxia-induced PVR mechanism 
that precedes CNV. Using transmission electron microscopy 
(TEM), confocal microscopy, histological analysis, and EC 
transcriptomics, we show that hypoxia treatment leads to ro-
bust endothelial proliferation, (productive) intussusception 
and formation of immature endothelial luminal processes 
(ELPs) that do not anastomose to form ISPs (nonproduc-
tive intussusception), as well as splitting of existing extra-
vascular columns. Remodeled choriocapillaris furthermore 
exhibited partially dissolved tight junctions, loosened mural 
cell contacts, increased fenestration, and increased permea-
bility. Hypoxia-induced vascular leakage and productive and 
nonproductive intussusception required high levels of VEGF-
signaling and the PVR phenotypes from the zebrafish model 
were recapitulated in a rat model of VEGF-induced chorio-
capillaris remodeling as well as in patients with advanced 
AMD. These findings establish intussusception as a novel 
mechanism involved in PVR preceding neovascularization in 
both animal models and patients.
Materials and Methods
The data that support the findings of this study are available from the 
corresponding author on reasonable request.
Zebrafish Strains and Their Maintenance
Tg(fli1a:EGFP)y1, Tg(kdrl:EGFP)s843, Tg(kdrl:DsRed2)pd27, 
Tg(acta2:EGFP)ca7, Tg(tagln:EGFP)p151, and Tg(gata1a:DsRed2)
sd2 transgenic strains46–51 were obtained from ZIRC, Oregon. 
Tg(fli1ep:Gal4FF)ubs3,52 Tg(UAS:RFP), Tg(UAS:VE- -EGFP)
ubs12,53 Tg(UAS:EGFP-ZO.1)ubs5,54 and Tg(UAS:EGFP-UCHD)
ubs1855 transgenic strains were from the Affolter laboratory and 
the Tg(pdgfrb:mcitrine;kdrl:DsRed2),56 Hif1aa−/−;Hif1ab−/−57 and 
Hsp70:VEGFAA-DN58 zebrafish lines were from the Stainier lab-
oratory. All strains and double or triple transgenic crosses between 
these stains were maintained at the Zebrafish facility at Linköping 
University, Linköping, Sweden following standard protocols.39,59 
All the experimental procedures have been previously approved by 
the Linköping animal ethics committee.
Hypoxia Exposure
The design of the hypoxia chamber and protocol for hypoxia expo-
sure of adult zebrafish have been described previously.33,34,40,42 Briefly, 
adult zebrafish between 6 and 12 months of age were acclimatized to 
progressively decreasing oxygen concentrations in the water over a 
period of 2 to 3 days and then kept in water with a relative air satura-
tion of 10% for 10 days.
Vegfaa-DN the fish were incubated for 1 hour at 37°C daily be-
tween day 4 and 10 of hypoxia exposure. DMH4 (Sigma Aldrich) was 
added to the water from a 1000X stock in DMSO to a final concen-
tration of 1 µmol/L.
Zebrafish Euthanasia and Dissection
Zebrafish were anesthetized with 0.04% MS-222 (Ethyl 3-aminoben-
zoate methane sulfonic acid salt 98%, Sigma Aldrich) for 5 minutes 
and transferred to ice cold water for an additional 5 minutes. Fish 
were fixed in 4% PFA (Sigma Aldrich) for 24 hours at 4°C, and the 
eyes were dissected to isolate the retina or choroid as described ear-
lier33,44 under a dissection microscope (Nikon SMZ 1500).
Evaluation of Vascular Leakiness
Vascular leakiness in adult zebrafish was evaluated essentially as 
described for embryos,60 by injection of 0.5 µL 70 kDa rhodamine-
labeled, lysine-modified dextran (Invitrogen, United States) IP with a 
10 µL syringe (Hamilton) under anesthesia with 0.02% MS-222. At 
15 minutes after the injection, the zebrafish were euthanized and fixed 
in 4% PFA for 24 hours at 4°C. Eyes were then dissected as described 
above and visualized by confocal microscopy as described below.
Fluorescence-Activated Cell Sorting
To obtain choroid ECs, adult fli1a:EGFP zebrafish were euthanized, 
and the choroids were isolated by manual dissection in ice-cold PBS 
(w/o Mg++ or Ca++, Gibco). Tissues were cut into fine pieces and 
placed in an equal volume of a mixture of collagenase (2.5 mg/mL 
Worthington Biochemical Corporation cat number LS004176) and 
DNase (30 U/μL, SIGMA, to a final of 0.04 mg/mL) in PBS (Mg++ 
and Ca++, Gibco) for 30 minutes on a shaker. Cells were filtered 
through a cell strainer (40 μm mesh, FALCON) followed by addition 
of 10% FBS:DMEM to a final volume of 6 mL and centrifugation at 
800g, +4°C for 5 minutes. The supernatant was removed, and cells 
were recovered in 1.5 mL of cold PBS with 2% FBS before flow 
cytometry in a BD Influx (Becton Dickinson) cell sorter.
RNA-Sequencing
ECs from control or hypoxia-treated zebrafish choroids were isolated 
by fluorescence-activated cell sorting (FACS). Cell samples (contain-
ing 30, 60, or all [>1000] EGFP-positive cells) were further processed 
for total RNA (RNeasy Micro Kit, Qiagen) followed by pre-RNA 
Sequencing procedures. Libraries were prepared using SMARTer 
Ultra Low Input RNA for Illumina Sequencing kit (Clontech) and 
sequenced on an Illumina HiSeq 2000. Reads were aligned with STAR 
(spliced transcripts alignment to a reference). As quality control, we 
calculated Spearman correlation between samples and removed the 
worst samples. All samples within each group were comparable after 
multiple testing correction. Raw data and expression values have 
been deposited to NCBI Sequence Read Archive with ID SRP056125 
and Gene Expression Omnibus with ID GSE66848. False discovery 
rates were calculated by the Benjamini-Hochberg method.
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Upregulated and downregulated genes from RNA-sequencing 
data were classified into functional annotation clusters using 
DAVID61 available at https://david.ncifcrf.gov/home.jsp. All the anal-
ysis parameters were kept at default. Only annotation clusters with 
enrichment score >1 were considered significant.
Immunohistochemistry
Fixed eyes from adult zebrafish were washed 3× with PBS and fur-
ther incubated in PBS for 2 hours at room temperature or 24 hours 
at 4°C. Retinal or choroid tissues were isolated by careful dissec-
tion and incubated in Proteinase K (20 µg/mL) for 5 minutes at room 
temperature on a rocking table. Tissues were then incubated for 
30 minutes at room temperature in absolute methanol followed by 
0.3% Triton–X PBS (PBS-Tx) for 30 minutes at room temperature 
on the rocking table followed by blocking in 3% milk in PBS-Tx 
overnight (16–24 hours) at 4°C. After washing 3× in PBS-Tx, tissues 
were incubated in primary antibodies Zo-1 (4 µg/mL, Invitrogen), 
VE-Cadherin (1:100 dilution),62 or monoclonal anti-GFAP (glial fi-
brillary acidic protein, 1:50 dilution, Sigma), diluted in 0.3% PBS-Tx 
100 for 24 hours at 4°C. Tissues were then washed 3× in PBS-Tx 100, 
incubated in PBS-Tx for 90 minutes at +4°C, reblocked in 3% milk 
PBS-Tx 100 for 90 minutes at room temperature and incubated with 
secondary antibody; Alexa flour 555, goat anti-rabbit (1:200 dilution, 
Life Technologies) at a concentration of 10 µg/mL in blocking buffer, 
overnight at +4°C. Tissues were washed 3× in PBS-Tx and incubated 
overnight in blocking solution and finally mounted within viewing 
chambers in Vectashield (Vector).
For phalloidin staining, the samples were washed 3× for 5 min-
utes with 0.1% Tween-20 in PBS. The tissues were permeabilized 
in 2% PBS-Tx 100 for 1.5 hours at room temperature. Tissues were 
stained with phalloidin 5 U (1:40 dilution, Life Technologies) diluted 
in 2% PBS-Tx at 4°C overnight on a rocking table in the dark. The 
next day, tissue samples were washed 5× in 0.1% Tween-20 in the 
dark, followed by mounting as described above.
Human Choroidal and Retinal EC Isolation, 
Hypoxia Treatment, and Quantitative PCR Analysis
Isolation of human choroidal and retinal ECs was described previ-
ously.63 Choroidal and retinal ECs were cultured and incubated either 
at normoxia (20% O2, 5% CO2) or exposed to 12 hours of hypoxia (1% O2, 5% CO2) in a humidified incubation chamber at 37°C when 
cells reached 80%–90% confluence. Total RNA was extracted from 
hypoxic and normoxic choroidal and retinal ECs (RNeasy minikit; 
QIAGEN). cDNA synthesis was performed from 500 ng total RNA 
(iScript cDNA Synthesis Kit BioRad Laboratories), and quanti-
tative PCR was performed by iQ SYBR Green Supermix using 
MyiQ SingleColor Real-Time PCR Detection System (BioRad 
Laboratories). All protocols were performed according to the manu-
facturer’s instructions. Gene expression differences were calculated 
by the ΔΔCt method from 3 independent experiments, with hTBP 
(human TATA box-binding protein) as a reference gene. The primer 
sets were purchased from Eurogentec (BioNordika Sweden AB), and 
sequences are listed in the online-only Data Supplement.
Electron Microscopy Sample Preparation
Specimens were fixed in a mixture of 2.5% glutaraldehyde and 4% 
formaldehyde in 0.1 mol/L Na cacodylate, pH 7.4, for 3 hours at 
room temperature. Specimens were washed with 0.1 mol/L Na cac-
odylate buffer and post fixed in 2% osmium tetroxide buffered in 0.1 
mol/L Na cacodylate at 4°C. After 1-hour specimens were washed 
2× with 0.1 mol/L Na cacodylate buffer and 3× with distilled water. 
Staining with 1% aqueous uranyl acetate was performed en block at 
4°C for 1 hour. Specimens were then washed 3× with distilled water 
and dehydrated in a series of ascending concentration of ethanol and 
propylene oxide. Infiltration took place in 3 steps and finally the 
samples were embedded in Araldite 502/Embed 812 embedding me-
dium at 60° for 24 hours (according to the manufacturer’s protocol, 
Electron Microscopy Science, Industry Road Hatfield, United States).
Electron Microscopic Analysis
Blocks were trimmed and sectioned by using a Reichert Ultracut 
S, Leica ultramicrotome. Semithin sections (1 µm thickness) were 
stained with 1% toluidine blue in 1% boric acid. Ultrathin sections 
(70 nm thickness) were collected onto formvar-coated, slot grids, 
and counterstained with uranyl acetate and lead citrate. The obser-
vation and examination of the sections took place on a 100 kV Jeol 
JEM1230 transmission electron microscope.
EM of Donor Eyes
Typical images of human donor eyes with and without AMD of an-
other study64 were selected for this work. Healthy aged eyes without 
known ophthalmic diseases were obtained from the Eye Hospital 
Tuebingen. A glutaraldehyde-fixed tissue sample of the perimacular 
central region of an AMD donor eye (76 years, male) was obtained 
from the Foundation Fighting Blindness (United States). Written in-
formed consent of all donors for use in medical research and addi-
tional approval of the Institutional Review Board of the University of 
Tuebingen were obtained. The experiments were performed in adher-
ence to the tenets of the Declaration of Helsinki.
VEGF-Induced Choriocapillary Remodeling in Rats
Six-week-old Long Evans rats were anesthetized and injected subreti-
nally with 2 µL (2×109 infectious units) of an adeno-associated virus 
(subtype 2.4) carrying the VEGF gene diluted in PBS. The vector 
was constructed and the research performed as described earlier for 
adenovirus in rabbits.65 Four weeks after injection, rats were eutha-
nized and the eyes were fixed in 4% glutaraldehyde and areas show-
ing CNV were embedded in EPON as described above for human 
donor eyes. The experiments were performed as approved by the 
Regierungspräsidium Tuebingen.
Paraffin Sections and H&E
The fish heads were submitted to 4% formaldehyde for a minimum of 
24 hours before dehydration in a series of alcohol followed by Tissue 
Clear (SAKURA Finetek) and embedding in paraffin (Histowax, 
Histolab). The paraffin-embedded fish heads were trimmed of par-
affin to reach the mid part of the eye, then sectioned in 4 µm sec-
tions and mounted 2 to 3 sections/slide on Superfrost plus slides 
(Thermofisher). After drying for 30 minutes, the sections were 
stained with Hematoxylin and Eosin using Ventana Symphony stain-
ing system (ROCHE).
Statistical Tests and Data Analysis
The data was found to pass the D’Agostino-Pearson normality test. 
Differences between groups were compared by 2-tailed Student t test. 
In cases where the groups of data exhibited significantly different 
variance (F test P value<0.05; Figures 2B, 3E, 4G, 4I, 4K, 4M, and 
4O), heteroscedastic t tests with Welsh correction for unequal vari-
ance was performed. For multigroup comparisons (Figures 1C and 
5D), the data exhibited equal variance (P>0.05 using the F test) and 
significance was evaluated using ANOVA with Turkey post hoc test. 
P values of <0.05 (*), 0.01 (**), or 0.001 (***) were considered sta-
tistically significant. The data is presented as means±SEM.
Results
Organization of Choroid and Retinal 
Vessels in Adult Zebrafish
Studies into the mechanisms underlying angiogenesis in vivo 
are often done using the postnatal retinal vascular develop-
ment model in mice.66,67 The retinal vasculature, however, is 
characterized by central nervous system–specific vascular 
barrier functions,26,68 which are not present in the choriocapil-
laris or other peripheral vasculatures. Investigating the physi-
ological and molecular mechanisms involved in pathological 
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changes in the choriocapillaris may therefore be important to 
gain insights into how such processes are operating in non-
barrier, peripheral vasculatures. Adult zebrafish offer unique 
opportunities for investigating the mechanisms underlying 
hypoxia-induced vascular pathology, but the zebrafish chorio-
capillaris has till date not been identified. Careful exploratory 
dissection of the adult zebrafish eye, revealed that it is highly 
comparable to that of mice and humans (Figure 1A through 
1C) including an anterior cornea (analogous to eyelids in 
mammals), posterior cornea, spherical lens (as in mice), thin 
vitreous, retina, porous RPE, Bruch’s membrane, choriocap-
illaris, and outer choroidal structures including a rete mira-
bile (analogous to the choroid body in humans and mice) and 
sclera. Using fli1a:EGFP46 and kdrl:EGFP47 endothelial re-
porter lines, we confirmed that retinal vessels at the vitreal 
surface of the retina were sparse (Figure 1B and 1C; Figure I 
in the online-only Data Supplement) and present only in the 
inner limiting membrane without vessels penetrating to deeper 
retinal layers (Figure 1B, 1E, and 1F; Figure I in the online-
only Data Supplement). We identified the zebrafish choriocap-
illaris, associated with Bruch’s membrane at the same location 
as in mammals, which compared to the retinal vasculature was 
extremely dense, constituting ≈95% of the tissue (Figure 1B 
through 1F; Figure I in the online-only Data Supplement). 
Vessels in the choroid body behind the choriocapillaris resem-
bled a rete mirabile and were also exhibiting a density sev-
eral-fold higher than that of the retinal vasculature at ≈70% 
(Figure 1B through 1F). In all 3 vasculatures (retinal vascula-
ture, choriocapillaris, and rete mirabile), the vessels received 
blood from primary branches of the central optic artery and 
were as such organized with arteries/arterioles in the center of 
the optic disc followed by capillaries and draining into venules 
and circumferential veins at the periphery of the optic disc 
(Figure 1B). Unidirectional blood flow from the center to the 
periphery in all 3 vasculatures supported efficient perfusion, 
as judged from the presence of gata1:DsRed positive eryth-
rocytes within kdrl:EGFP vessels in kdrl:EGFP;gata1:DsRed 
double transgenic zebrafish48 (Figure 1D). The differences in 
vascular density were confirmed by FACS-assisted counting 
of the number of EGFP+ ECs in either the retina or the cho-
roid, as well as by Western blot for EGFP expression (Figure 
I in the online-only Data Supplement).
Figure 1. Anatomy and functional characterization of retinal vessel (RV) and choroid vessel in adult zebrafish. A, Bright-field micrographs showing the 
gross anatomy of the adult zebrafish eye. The central choroid body containing the rete mirabile (RM) is located between the choriocapillaris (CCs), which is 
attached to Bruch’s membrane, and the sclera. A loose retinal pigment epithelium is evident between the retina and Bruch’s membrane. The lens, located 
between the cornea and the retina, has been removed from the preparation. B, Bright-field micrographs of retinal, CC, and RM flat mounts from adult 
Fli1a:EGFP zebrafish and confocal micrographs of the vessels contained in these tissues (RVs, CCs, and RM, respectively). Boxed regions are shown in 
magnified images on the right. Central (C) and peripheral (P) vascular beds are shown separately. Yellow arrows indicate arterial branches (A) from the central 
optic artery, which feed blood to these vasculatures. White arrows indicate the direction of blood flow. Blood is collected by circumferential veins (V). White 
arrowheads in the column to the right point to interstitial spaces, whereas yellow arrowheads point to vessels/lumens. Size bars indicate 500, 500, 50, 25, or 
25 μm in the first row and 100, 100, 50, 25, or 25 μm for row 2 and row 3. C, Quantification of the vascular density of the vasculatures shown in B. n=10–15. 
ANOVA, P<0.001, Tukey post hoc: ***P<0.001. D, Confocal micrographs of the adult RVs, CCs, and RM of kdrl:EGFP;gata1:DsRed adult double transgenic 
zebrafish. Endothelial cells are shown in green and erythrocytes in red. Size bars indicate 50 μm in each image. E and F, Bright-field (E) or confocal (F) micro-
graphs of whole retina cross-sections from paraffin-embedded adult fli1a:EGFP zebrafish eyes stained with hematoxylin and eosin. The location of the RVs, 
CCs, and RM are shown in black or white boxes, and higher magnification images of the boxed regions are shown to the right or left in E or F, respectively. 
Size bars indicates 20 μm and 50 μm in the high- vs low-magnification images, respectively.
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Consistent with central-to-peripheral organization 
of blood flow in the ocular vasculatures, we found using 
tagln:EGFP;kdrl:DsRed and acta2:EGFP;kdrl:DsRed double 
transgenic fish49,50 that all retinal vessels in the center of the optic 
disk were arteries densely covered with SM22-α/Tgn (trans-
gellin1) and Acta2 (α-smooth muscle actin)-positive smooth 
muscle cells (SMCs), which were not present in capillaries or 
venous vessels (Figure 2A and 2B; Figure II in the online-only 
Data Supplement). Using a pdgfrb:Citrine;kdrl:DsRed double 
transgenic line,56 we found that retinal capillaries and veins 
were tightly covered with Pdgfrβ+ pericytes (Figure 2C and 
2D). In contrast, Tgn+/Acta2+/Pdgfrβ+ SMCs were present in 
the interstitial space throughout the choriocapillaris and sent 
out thin membranous projections that only sparsely covered the 
Figure 2. Detailed analysis of retinal vessels (RVs) and choriocapillaris (CCs) in adult zebrafish. A and C, Confocal micrographs of RVs and CCs from 
Kdrl:DsRed;Transgellin:EGFP (kdrl-tgn [transgellin1]) or Kdrl:DsRed;Pdgfrb:EGFP (kdrl-pdgfrb) double transgenic adult zebrafish. Endothelial cells are shown 
in red and smooth muscle cells (A) or pericytes (C) in green. Boxed regions are shown in the magnified images below. White arrowheads point to extensions 
of Tgn+ or Pdgfrb+ perivascular cell projections. Size bars indicate 100 μm for retinal vessels and 50 μm for CCs. B and D, Quantification of the percentage of 
the EGFP+ endothelium that was covered by Tgn+ (B) or Pdgfrb+ (D) cells in the experiment shown in A and C. n=5–10. ***P<0.001. E, Confocal micrographs 
of RVs or CCs from Fli1a:EGFP adult zebrafish stained with an anti–ZO (zonula occludens)-1 antibody showing endothelial cells in green and tight junctions 
in red. White arrowheads point to double-positive signals in the vessel wall. Size bars indicate 100 μm in retinal vessels and 50 μm in CCs, respectively. F, 
Quantification of the percentage of the EGFP+ endothelium that was stained with the anti–ZO-1 antibody in the experiment shown in E. n=10–15. ***P<0.001. 
G, Confocal micrographs of RVs, CCs, muscle and skin vessels from plvap:EGFP transgenic zebrafish. Cells expressing PLVAP are shown in green. Size bars 
indicate 50 μm. H and I, Transmission electron micrographs of RVs (H) or CCs (I). Size bars indicate 2 μm. White arrows/arrowheads point to tight junction 
(TJ), pericytes (P, outlined with white dots), basement membrane (BM), vesicles (V), fenestrations (F), and endothelial luminal pillars (ELPs) as indicated. A 
indicates arterial region; C, capillary region; and NS, nonsignificant.
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endothelium (Figure 2A through 2D; Figure II in the online-
only Data Supplement). To investigate molecular indicators of 
endothelial barrier function in more detail, we stained retinal or 
choriocapillaris tissues using antibodies against bona fide vas-
cular barrier markers. GFAP-positive glial cells were densely 
covering retinal capillaries but were not present in the chorio-
capillaris (Figure IIIB in the online-only Data Supplement). 
Furthermore, tight junction markers ZO (zonula occludens).1 
and VE-Cadherin (ie, cdh5) were both highly expressed in ret-
inal capillaries but only sparsely expressed in the choriocapillaris 
endothelium (Figure 2E and 2F; Figure IIIA in the online-only 
Data Supplement). Interestingly, in the choriocapillaris, ZO.1 
was robustly expressed by the SMCs (Figure 2E). To investigate 
whether the zebrafish choriocapillaries are fenestrated, similar 
to other peripheral capillary beds in for example the muscle and 
skin, but opposite to capillaries in the central nervous system in-
cluding the retina, we evaluated the expression of the fenestra-
tion marker PLVAP (plasmalemma vesicle-associated protein; 
Meca32) using a newly developed transgenic reporter line.69 
PLVAP was highly expressed in the choriocapillaris, as well as 
in capillaries of the muscle and skin, but not in the retinal endo-
thelium of adult zebrafish (Figure 2G).
Consistent with the histological results, TEM analysis re-
vealed that zebrafish retinal capillaries were richly covered 
with pericytes and a continuous basement membrane shared by 
both pericytes and ECs. Tight junctions were clearly apparent 
at EC-EC cell junctions, and the endothelium contained nu-
merous vesicles indicative of active transport of substances 
across the blood-retinal barrier (Figure 2G). No fenestrations 
could be observed in the retinal capillary endothelium. On the 
contrary, choriocapillaries were sparsely associated with SMCs 
and basement membrane, exclusively at the scleral side. The 
retinal side was instead closely associated with Bruch’s mem-
brane, fenestrated and contained only few, small vesicles as the 
endothelium was very thin. Interendothelial tight junctions were 
present but short and poorly developed compared to in the retina 
(Figure 2H). Taken together, these findings demonstrate that the 
choriocapillaris in adult zebrafish are highly similar to chorio-
capillaris in humans, and that they are comparable to peripheral 
capillaries, whereas retinal vessels are comparable to retinal and 
brain vessels in humans and both functionally and morpholog-
ically different from choriocapillaris and peripheral capillar-
ies. Interestingly, a few endothelial luminal projections (ELPs; 
Figure 2G and 2H) could occasionally be observed in the adult 
zebrafish choriocapillaris, structures that may represent early 
stage ISPs suggesting that physiological, continuous remodel-
ing of the choriocapillaris occurs through intussusception.
Hypoxia Induces Pathological Choriocapillaris 
Remodeling by Intussusception
Hypoxia is considered a main pathophysiological driver of neo-
vascularization in both health and disease.30,70 To investigate 
Figure 3. Hypoxia-induced pathological vascular remodeling in the choriocapillaris (CCs). A and B, Confocal micrographs of CCs from adult fli1a:EGFP (A) or 
fli1a:nEGFP (B) zebrafish exposed to water with 100% (normoxia) or 10% (hypoxia) relative air saturation for 10 d. Boxed regions are shown in A magnified 
images below. White arrowheads point to extravascular columns, double white arrows indicate split columns. Yellow arrowheads point to endothelial nuclei. 
Size bars indicate 50 μm. C, Confocal micrographs of CCs from adult fli1a:nEGFP zebrafish. Quantification of the number of extravascular columns from the 
experiment shown in A. n=10–15. ***P<0.001. D, Quantification of the vascular density in the CCs from the experiment shown in A. n=10–15. ***P<0.001. 
E, Quantification of the column area from the experiment shown in A. n=10–15. **P<0.01. F, Quantification of the number of endothelial nuclei per CC area 
from the experiment shown in B. n=10. ***P<0.001. G, Imaris rendering illustrating the 3-dimensional structure of the vasculature and extravascular columns 
viewed from outside (top 2 rows) or inside the CC lumen (lower 2 rows) from the experiment shown in A. Image in the lower row is from the hypoxia group. 
White arrowheads point to full intussusceptive pillars and red arrowheads point to incomplete pillars/endothelial luminal pillars.
D
ow
nloaded from
 http://ahajournals.org by on November 4, 2019
Ali et al  Intussusception Precede Neovascularization  1409
if hypoxia treatment affects adult zebrafish choriocapillaris, 
fli1a:EGFP zebrafish were placed in water which was ren-
dered hypoxic through perfusion of N2 gas until reaching a 
level of 10% relative air saturation (ie, ≈2% oxygen), which 
was then maintained for 10 days.33,34,42 Hypoxia-treated zebraf-
ish were then compared to control animals exposed to 100% 
relative air-saturated water. Surprisingly, 10 days of hypoxia 
treatment did not lead to an increase in choriocapillaris sprout-
ing (Figure 3A), unlike what had been previously observed 
in the retinal vasculature,33,34 nor did hypoxia induce vascular 
invasion through Bruch’s membrane and into the subretinal 
space. However, a robust induction of additional, circular 
transluminal, extravascular columns through the choriocap-
illaris was observed in hypoxia-treated compared to control 
zebrafish, and these columns had a reduced mean area lead-
ing to increased overall vascular density (Figure 3A through 
3E). Furthermore, many of the columns in hypoxia-treated 
fish seemed to be in close contact with each other, separated 
only by a thin endothelial membrane (Figure 3A; white double 
arrows). In addition, hypoxia treatment induced a pronounced 
proliferation of choriocapillaris ECs, as indicated by conden-
sation and duplication of nuclear-restricted EGFP within ECs 
as well as an increase of total EC nuclei (Figure 3B and 3F). 
To validate that the zebrafish eyes were indeed hypoxic in the 
hypoxia-treated fish, we strained retinal cross-sections with 
antibodies recognizing HIF-1a or HIF-2a, proteins that should 
be unstable and therefore not detectable under normoxic con-
ditions. In the outer nuclear layer, the most metabolically 
active area in the retina, of hypoxia-treated fish, HIF-1a and 
HIF-2a immune-positivity was markedly elevated (Figure IV 
in the online-only Data Supplement), demonstrating that these 
proteins were indeed stabilized by the hypoxia treatment.
Elevated blood pressure, leading to increased mechanical 
stimulation of the endothelium, affects vascular growth and 
remodeling.71 As hypoxia treatment is known to cause blood 
pressure elevation in zebrafish,42 we tested whether increased 
blood pressure by itself would affect the choriocapillaris in a 
similar manner as in hypoxia-treated fish. Increasing the blood 
pressure by treatment with the β-adrenergic receptor agonist 
Clenbuterol for 10 days did not, however, lead to an increase in 
ISPs, and the choriocapillaris remained indistinguishable from 
those in control fish, suggesting that hypertension alone did not 
cause changes to the choriocapillaris in hypoxia-treated zebraf-
ish (Figure V in the online-only Data Supplement).
To identify the structural processes underlying hypoxia-
induced intussusception in the zebrafish choriocapillaris, we 
analyzed the 3-dimensional (3D) structure of the extravas-
cular columns and the intravascular lumens of control and 
hypoxia-treated fish using Imaris rendering of high-power 
3D-confocal z-stacks. Interestingly, numerous incomplete 
extravascular columns were apparent in the intravascular 
lumen of hypoxia-treated but not in control fish (Figure 3G; 
red arrowheads), providing further evidence for ongoing 
hypoxia-induced intussusception. In addition, we also found 
that existing extravascular columns were split to generate 
multiple, smaller, closely associated columns specifically in 
the hypoxia-treated fish (Figure 3G). Such splitting of extra-
vascular columns appeared to involve active cleavage of the 
columns by EC processes that expanded from one side of the 
column to anastomose with a projection or endothelial surface 
at the opposing side. These processes quickly became lumen-
ized to support perfusion around the now 2 (or more) separate 
extravascular columns (Figure 3G). As such, hypoxia-induced 
intussusception occurred both by de novo ISP formation and 
by splitting of existing extravascular columns.
Next, we investigated the molecular mechanisms under-
lying hypoxia-induced intussusception in the choriocapillaris 
by sequencing RNA isolated from EGFP+ ECs collected by 
FACS from hypoxia-treated or control zebrafish choriocapil-
laris membranes (Figure 4A). As expected, EC populations 
expressed high levels of classical EC markers including fli1a, 
fli1b, flt1, kdr, tie1, and tek (Table II in the online-only Data 
Supplement), whereas genes associated with other vascular or 
choroidal cell types such as neurons (dbx1, dbx2), glia cells 
(gfap, aldh1a3, mbp, pax6a, pax6b, calb2), SMCs (desm, 
abcc9, kcnj8), or pericytes (cspg4, desm) were not significantly 
expressed (ie, RPKM [reads per kilobase million] <5; Table 
III in the online-only Data Supplement), confirming that we 
had obtained a highly EC enriched population of cells. Only 
3 genes, hbz, hbbe2, and ccl34a.4 (si:ch211-122l24.4), were 
significantly deregulated (induced) in the hypoxia-treated fish 
using a false discovery rate <0.05 (Table IV in the online-only 
Data Supplement). These genes encode 2 hemoglobin isotypes 
and a protein known to be involved in hematopoiesis, all 3 
genes being specific for erythroid cells72 and therefore likely 
expressed in circulating fli1a-positive hematopoietic progen-
itor cells present in the choriocapillaris at the time of cell iso-
lation, rather than in the vascular EC population. Nevertheless, 
these findings demonstrate that the fish were exhibiting ex-
pected physiological adaptations to long-term hypoxia such as 
increased erythropoiesis. Using instead a less rigorous cutoff 
(P<0.05), a total of 2087 upregulated and 1052 downregu-
lated transcripts (Figure 3E; Table IV in the online-only Data 
Supplement) were identified. Using an in house algorithm73 to 
analyze these genes for the presence of hypoxia-responsive 
elements in their promoters, we could demonstrate that di-
rectly HIF-responsive genes were not enriched in this set of 
genes (Figure VI in the online-only Data Supplement). This 
likely implies that the expression of the majority of deregulated 
genes was controlled by hypoxia-regulated transcription fac-
tors rather than the HIFs themselves, under these experimental 
conditions. Using the DAVID functional annotation tool, we 
found that the majority of the deregulated genes clustered 
into a total of 13 upregulated and 9 downregulated pathways 
(Figure VII in the online-only Data Supplement). Interestingly, 
18 of these 22 pathways had very similar biological functions 
and could be assembled into 4 pathway families (Figure 4B). 
These 4 families included pathways involved in vesicle bio-
genesis, cytoskeletal rearrangements and ciliogenesis, regula-
tion of cellular metabolism and ECM (extracellular matrix) or 
tight junction remodeling. Changes in cellular metabolism are 
expected in response to hypoxia, but the remaining 3 pathway 
families have not been strongly coupled to hypoxia or hypoxia-
induced vascular growth or remodeling in the past. Using 
phalloidin staining and a fli1a:GFF;UAS:RFP;UAS:UCHD-
EGFP triple transgenic zebrafish strain55 in which an EGFP-
fused utrophin calponin homology domain protein, binding 
specifically to f-actin, was expressed in ECs, extravascular 
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pillars, and ELPs indicative of early ISPs were found to be 
strongly enriched for f-actin, which was not observed in the 
endothelium outside of these structures (Figures VIII and IX 
in the online-only Data Supplement). These findings support 
the involvement of the actin cytoskeleton in the observed 
hypoxia-induced intussusception in the choriocapillaris. Taken 
together these results strongly suggest that hypoxia may drive 
intussusceptive choriocapillaris growth through a mechanism 
involving membrane and cytoskeletal rearrangements in ECs.
Hypoxia Treatment Drives Nonproductive 
Intussusception and Leakage in the Choriocapillaris
To further analyze how pathways involved in vesicle bio-
genesis, cytoskeletal dynamics/ciliogenesis, and ECM/tight 
Figure 4. Hypoxia-induced remodeling of the choriocapillary (CC) pillars and endothelium. A, Schematic representation of the processes to obtain and 
sequence RNA from endothelial cells (ECs, shown in green) in the CCs of adult zebrafish. B, Schematic representation of the hypoxia-induced or hypoxia-
repressed transcriptomic changes (P<0.05) in adult CCs ECs and families of functional annotation clusters (each with a DAVID enrichment score >1.0) in 
which the upregulated and downregulated genes cluster. All clusters are shown in Figure VII in the online-only Data Supplement. The numbers of clusters 
included in each family and the cumulative DAVID enrichment scores are indicated. C, Transmission electron micrographs from the CCs of adult fli1a:EGFP 
zebrafish exposed to water with 100% (normoxia) or 10% (hypoxia) relative air saturation for 10 d. Boxed regions are shown in magnified images at the right. 
White arrowheads point to endothelial thickness (ET), vesicles, fenestrations, tight junctions (TJs), or endothelial luminal processes (ELPs) as indicated. Black 
size bars indicate 250, 500, or 2000 nm as indicated. D–I, Quantification of the number (D) or size (E) of fenestrations and the endothelial thickness (F), in 
either the scleral or retinal pigment epithelium (RPE)-sides of the CCs, the number of vesicles (G) and ELPs (H) and the height of the ELPs (I) from the experi-
ment shown in C. n=5–10.*P<0.05, **P<0.01, ***P<0.001. J, Confocal micrographs of CCs from normoxia or hypoxia-exposed adult fli1a:EGFP zebrafish (ECs 
shown in green) stained with an anti–ZO (zonula occludens)-1 antibody (red). Size bars indicate 50 μm. K, Quantification of the percentage of the EGFP+ en-
dothelium that was stained with the anti–ZO-1 antibody in the experiment shown in J. n=10–15. ***P<0.001. L, Confocal micrographs of adult fli1a:EGFP CCs 
(ECs shown in green) exposed to normoxia or hypoxia for 10 d and injected with 70 kDa Dextran (Dex, red). White arrowheads point to interstitial spaces, 
whereas yellow arrowheads point to lumens. Size bars indicate 50 μm. M, Quantification of the relative percentage of interstitial dextran compared to the total 
signal from the experiment shown in J. n=15–20. ***P<0.001. N, Confocal micrographs of CCs from normoxia or hypoxia-exposed adult fli1a:EGFP zebrafish 
(ECs shown in green) stained with an anticollagen I antibody (red). Yellow arrowheads point to columns filled with collagen I–positive fibers. Size bars indi-
cate 50 μm. O, Quantification of the number of columns (in percent) containing collagen I fibers in the experiment shown in N. n=10. ***P<0.001. P, Confocal 
micrographs of CCs from normoxia or hypoxia-exposed adult kdrl:EGFP;tgn:DsRed double transgenic zebrafish (ECs shown in green and smooth muscle 
cells shown in red). Size bars indicate 50 μm. Q, Quantification of the number of columns (in percent) containing smooth muscle cells in the experiment 
shown in P. n=10. ECM indicates extracellular matrix; H, hypoxia; N, normoxia; and ns, nonsignificant.
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junction remodeling are involved during hypoxia-induced in-
tussusception and vascular remodeling, we performed TEM 
analysis on the choriocapillaris from control or hypoxia-
treated zebrafish. We found that hypoxia-treated zebrafish 
had an increased number and size of endothelial fenestra-
tions (Figure 4C through 4E; Figure X in the online-only 
Data Supplement) and a thickened endothelium (Figure 4C 
and 4F) in both the RPE- and scleral sides of the vascula-
ture. Furthermore, we found a dramatic induction of endo-
thelial vesiculation, with almost 6-fold more vesicles present 
in the endothelium of hypoxia-treated fish compared to nor-
moxia controls (Figure 4C and 4G). Interestingly, we also 
found a dramatically elevated number and size of ELPs, 
which often did not proceed to form mature intussusceptive 
transluminal pillars (ISPs; Figure 4C, 4H, and 4I). Often, 
a markedly thickened and heavily vesiculated endothelium 
coincided with ELP formation leading to congested lumens 
in these areas (Figure 4C; Figure X in the online-only Data 
Supplement). Such areas were never found in control fish. 
We did not find any evidence of perivascular cell processes 
in the ELPs, which consisted only of luminal sprouts from 
the ECs. As such, ELPs could possibly be considered large 
endothelial cilia and their formation likely controlled by 
the ciliogenesis pathways upregulated during hypoxia treat-
ment. Interestingly, we found that tight junctions were par-
tially dissolved in the choriocapillaris of hypoxia-treated fish 
(Figure 4C), which was confirmed by a reduction in ZO.1 
expression in both endothelial and SMCs (Figure 4J and 
4K). This phenotype was also supported by the transcrip-
tomic data demonstrating that pathways involved in tight 
junction remodeling were affected by the hypoxia treat-
ment (Figure 4B). Importantly, these pathological changes 
led to a prominent increase in leakage of rhodamine-conju-
gated, lysine-modified 70 kDa Dextran (Figure 4L and 4M). 
Furthermore, areas in which the endothelium was open, in-
dicative of previous or ongoing hemorrhaging was present 
in several hypoxia-treated zebrafish, but never in controls 
(Figure X in the online-only Data Supplement). These areas 
Figure 5. HIF (hypoxia-induced factor)-1-VEGF (vascular endothelial growth factor)-A-VEGFR2 signaling is required for hypoxia-induced pathological choriocapil-
lary (CC) remodeling in zebrafish. A, Analysis of Vegfr1, Vegfr2a (kdrl), or Vegfr2b (kdr) mRNA expression in CCs from normoxia (N) or hypoxia (H) exposed adult 
fli1a:EGFP zebrafish, normalized to the expression of Fli1a. n=26. ***P<0.001. B, Quantitative PCR analysis of Vegfaa, Vegfab, Plgf (placental growth factor), or 
Vegfb mRNA expression in CCs from normoxia (N) or hypoxia (H) exposed adult fli1a:EGFP zebrafish, normalized to the expression of Gapdh. n=16–24. **P<0.01. 
C, Confocal micrographs of CCs from adult fli1a:EGFP zebrafish exposed normoxia or hypoxia and treated with DMH4, alternatively from adult hypoxia-exposed 
fli1a:EGFP zebrafish (Wt), fli1a:EGFP;hif1aa−/−;hif1ab−/− zebrafish (HIF1a−/−), or fli1a:EGFP;Hsp70:VEGFAA-DN zebrafish incubated for 1 h at 37°C daily from day 
4 of hypoxia treatment (Vegfaa-DN). White arrowheads point to hypoxia-induced extravascular columns in the CCs. Size bars indicate 25 µm. D, Quantifica-
tion of the number of extravascular columns in the CCs from the experiment shown in C. N=normoxia, H=hypoxia, Hi=fli1a:EGFP;hif1aa−/−;hif1ab−/− zebrafish, 
V=fli1a:EGFP;Hsp70:VEGFAA-DN zebrafish, D=DMH4-treatment zebrafish. n=10–15. ANOVA P<0.0053, Tukey post hoc: *P<0.05. NS indicates not significant.
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were often associated with a blot clot, as expected, but also 
a dramatically elevated number of ELPs, which presumably 
helped to constrict the lumen, reduce the bleeding, and heal 
the injury.
Next, we analyzed the composition of the extravascular 
columns in control or hypoxia-treated zebrafish. TEM anal-
ysis revealed that while collagen fibers were clearly pre-
sent in these columns under normoxic conditions, no such 
fibers could be detected in the columns of hypoxia-treated 
zebrafish (Figure XI in the online-only Data Supplement). 
Furthermore, while SMCs were still present in the columns 
under hypoxic conditions, the normally very tight associa-
tion between the SMCs and the endothelium found under 
normoxic conditions, was disrupted in hypoxia-treated 
zebrafish resulting in a loose association between the SMCs 
and ECs (Figure XI in the online-only Data Supplement). 
These findings were validated by immunohistological char-
acterization of collagen I content in the choriocapillaris. 
While collagen I–positive fibers were filling most of the 
extravascular columns in normoxic fish, such fibers were 
completely absent in hypoxia-treated fish (Figure 4N and 
4O), whereas overall SMC investment was not changed 
(Figure 4P and 4Q).
Collectively, these results demonstrate that signaling path-
ways involved in vesicle biogenesis, cytoskeletal dynamics, 
ciliogenesis, and tight junction remodeling coupled to a degra-
dation of collagen fibers and a loosening of EC-SMC contacts 
are functionally linked to hypoxia-induced PVR.
HIF-1α-VEGFA-VEGFR2 Signaling Is Critical 
for Hypoxia-Induced PVR in Zebrafish
One of the main hypoxia-induced factors mediating patho-
logical vascular phenotypes in disease is VEGF-A.74 Using 
quantitative PCR we investigated the expression of VEGF-
ligands and receptors in whole choriocapillaris membranes 
from control and hypoxia-treated zebrafish and found that 
Vegfaa, Vegfab, Vegfb, Plgf (placental growth factor), Vegfr1, 
Vegfr2a, and Vegfr2b, mRNAs were expressed in both 
hypoxia-treated and control zebrafish. Only Vegfaa, cod-
ing for the primary zebrafish VEGF-A ligand was, however, 
upregulated in hypoxia-treated fish (Figure 5A and 5B). 
Furthermore, Vegfr2a (Kdrl) coding for the main VEGF-
receptor was expressed at higher levels compared to the 
other receptors (Figure 5A). Using immunohistochemistry, 
we found that phosphorylation of VEGFR2 was increased 
in both retinal vessels and choriocapillaris of hypoxic fish, 
and that known VEGF-induced or VEGF-repressed genes75–80 
were similarly regulated in the ECs from the choriocapil-
laris of hypoxia-treated fish compared to normoxic controls 
(Figure XII in the online-only Data Supplement).
Next, using newly developed genetic loss-of-function 
models including a HIF-1αa/HIF-1αb-double knockout 
strain,57 a heat-shock inducible VEGFA-dominant nega-
tive strain,58 and a specific inhibitor of VEGFR2 (when 
used at doses that does not inhibit VEGFR1-signaling79,80), 
we found that hypoxia-induced intussusception was com-
pletely blocked under these 3 conditions (Figure 5C and 5D). 
Combined these results demonstrate that hypoxia-induced 
intussusception in zebrafish occurred through the HIF-1α-
VEGFA-VEGFR2 pathway.
Productive and Nonproductive Intussusception 
Is Associated With PVR in Wet AMD
Next, we investigated the expression of VEGF-receptors in 
adult mouse choriocapillaris by immunohistochemistry. Both 
VEGFR1 and VEGFR2 were strongly expressed by the cho-
riocapillaris endothelium (Figure 6A and 6B). To investigate 
if this was also the case in humans, we purified ECs from the 
choroid of a donor with no history of ocular disease.63 These 
ECs were then hypoxia-treated to simulate the pathological 
condition in the zebrafish model. Also in human choroid 
ECs, hypoxia treatment produced a VEGFR2-biased signal-
ing cascade by downregulating VEGFR1, considered to be a 
negative inhibitor of VEGFR2 signaling,60 and upregulating 
VEGFA, while neither significantly changing the expression 
levels of VEGFR2 itself nor the VEGFR1-only ligand PlGF 
(Figure 6C and 6D). To further demonstrate that VEGFA sig-
naling may lead to the phenotypes observed in the zebrafish, 
we took advantage of a gain-of-function adeno-associated 
virus delivery system to overexpress VEGFA in the rat cho-
roid. PVR in adeno-associated virus-VEGFA-treated rats was 
investigated by TEM. This analysis clearly demonstrated that 
VEGFA-conditioned choriocapillaris developed numerous, 
enlarged fenestrations, disrupted tight junctions, thickened 
and highly vesiculated endothelium, a high number of ELPs 
and occasionally open areas of the endothelium, thus accu-
rately phenocopying the PVR observed in hypoxia-treated 
zebrafish (Figure 6E; Figure IX in the online-only Data 
Supplement).
To further translate the role of functional and non-
functional intussusception in PVR associated with CNV, 
we analyzed choriocapillaris from AMD patients and 
non-AMD controls by TEM. As observed during hypoxia-
induced PVR in zebrafish and VEGF-A–induced PVR 
in rats, the pathologically activated, but not neovascular 
choriocapillaris in AMD patients, were characterized by a 
large number of ELPs, a few of which connected with ELPs 
from the opposing side to form primitive ISPs, suggesting 
that productive and nonproductive intussusception is also 
important for PVR in humans (Figure 6F). Furthermore, 
the endothelium was markedly thickened and vesiculated, 
tight junctions were partially dissolved and enlarged fen-
estrations were present (Figure 6F and 6G), phenotypes 
closely resembling those found in the zebrafish and rat 
models.
In summary, the data presented here reveal a novel type 
of PVR that precede sprouting and neovascularization in the 
choriocapillaris of hypoxia-treated adult zebrafish, VEGFA-
treated rats and in AMD patients. Mechanistically, PVR was 
mediated by HIF-1-VEGFA-VEGFR2 signaling, and involved 
intussusception associated with the local congestion of cho-
riocapillaris lumens through endothelial thickening, vesic-
ulation, and ELP formation (collectively referred to here as 
nonproductive intussusception) as well as productive split-
ting of existing extravascular columns by degradation of their 
collagen core followed by extension of endothelial processes 
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through the columns. In addition, dissolved tight junctions 
and enlarged fenestrations in hypoxia-treated fish mediated 
vascular leakage and likely drive disease progression in AMD 
at an earlier stage, before CNV (summarized in Figure 7).
Discussion
Inhibiting or reversing pathological neovascularization has 
emerged as an important concept in treatment of a variety 
of disorders including cancer and eye diseases such as AMD 
and DR.2,12,25 The anti-VEGF drugs in clinical use today are 
offered to patients diagnosed with advanced, neovascular di-
sease stages with the goal to achieve regression of the patho-
logical, ectopic vasculature present in the tissue thus avoiding 
further damage due to vascular dysfunction.6,8,10 These treat-
ments often provide short-term therapeutic benefit due to 
initial regression of immature neovessels, but most patients 
sooner or later develop refractory disease characterized by 
resumed pathological neovascularization arising from the 
matured neovessels that remain after anti-VEGF treatment in 
the diseased tissue. As such, many patients eventually prog-
ress in spite of continued treatment.12 As anti-VEGF drugs 
can be toxic when given systemically and for long periods of 
time, treatment schedules often include drug holidays, which, 
however, may be associated with worsened prognosis of some 
patients, presumably due to rebound neovascularization in the 
treatment-free periods.83,84 It is likely that if antineovascular 
Figure 6. Pathophysiological changes in the choriocapillaris (CCs) in adult zebrafish are recapitulated in mice, rats, and human wet age-related macular de-
generation (AMD) patients. A, Confocal micrographs of CCs from adult C57/Bl6 mice (m) stained with anti-CD31 (blue), anti-VEGFR1 (red), and anti-VEGFR2 
(green) antibodies. Boxed regions are shown in the magnified images below. White arrowheads indicate interstitial areas/extravascular columns. Size bars 
indicate 100 µm for the top row and 20 µm for the lower row. B, Quantifications of the percentage of the CD31+ endothelium that was costained with the 
VEGFR (R1) and VEGFR (R2) antibody in the experiment shown in A. n=3. C, Quantitative PCR analysis of Vegfr1 and Vegfr2 mRNA expression in primary 
human choroidal endothelial cells (hChoroid) in culture following 12 h of treatment with normal oxygen (normoxia, N) or 1% oxygen (hypoxia, H), normalized 
to the expression of TATA box-binding protein. n=3. *P<0.05. D, Quantitative PCR analysis of Vegfa or Plgf expression in primary human choroidal ECs (hCho-
roid) subjected to normoxia or hypoxia as in C. n=3. *P<0.05, ***P<0.001. E, Transmission electron micrographs of rat CC remodeling following adeno-associ-
ated virus-mediated VEGF (vascular endothelial growth factor)-A overexpression in the outer retina/subretinal space. Boxed region is shown in the magnified 
image to the right. White arrows point to endothelial luminal processes (ELPs), tight junctions (TJs), vesicles (V), endothelial thickness (ET), and fenestrations, 
as indicated. F, Transmission electron micrographs of human occult choroidal neovascularization (CNV) or non-CNV control CCs. Boxed regions are shown 
in magnified images to the right. White arrows point to ELPs and ET. Size bars indicate 2 μm or 1 μm, respectively. G, Transmission electron micrographs of 
details from human occult choroidal neovascularization (oCNV) or non-CNV control choriocapillaris. White arrows point to fenestrations (F) and TJs, as indi-
cated. Size bars indicate 1 μm. NS indicates not significant.
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drugs are given at early disease stages, where pathological 
vascular activation and remodeling has not yet progressed 
to ectopic neovascularization, they could potentially prevent 
progression to advanced disease, and provide more effective, 
long-term disease control. Methods to identify early changes 
in blood vessels preceding neovascularization are however 
lacking as the underlying mechanisms are poorly understood. 
Whereas some diseases such as cancer have already progressed 
to neovascular stages on diagnosis, AMD patients are often 
diagnosed at preneovascular stages, and regularly monitored.9 
As such, given a robust clinical indication of initial vascular 
changes preceding neovascularization, there is a real chance 
that this could translate to earlier treatment aiming at pre-
venting progression to advanced disease and retained vision 
in AMD patients. Clinically, the PVR phenotypes discovered 
here would likely imply changes in blood flow or leakage that 
could be evaluated today using modern imaging techniques 
such as fluorescein and optical coherence tomography angiog-
raphy.85 Examinations based on these techniques could poten-
tially be developed and used as a clinical readout for increased 
risk of developing neovascular disease, which could indicate 
the use of preventive antineovascular drugs in the future.
Using a novel adult zebrafish model whereby the long-
term effects of hypoxia on the choriocapillaris could be 
studied, we delineated a previously unidentified PVR and 
leakage mechanism in the choriocapillaris, which was evi-
dent before signs of CNV and involved increased endothelial 
fenestration, dissolution of tight junctions, endothelial vesic-
ulation and thickening, and productive and nonproductive in-
tussusception. Likely due to the extremely high density of the 
choriocapillaris at baseline,86 we found that splitting of extra-
vascular columns by fusion of endothelial processes from ECs 
on opposing sides of the column, coinciding with robust en-
dothelial proliferation, played a major role in further increas-
ing vascular density in the choriocapillaris following hypoxia 
treatment. We further demonstrate that these phenotypes 
also dominate PVR associated with choriocapillaris vascular 
lesions that had not yet penetrated through Bruch’s membrane 
in rats and humans. Vascular remodeling and leakage were 
transcriptionally linked to pathways involved in cytoskel-
eton remodeling and ciliogenesis, vesicle biogenesis, ECM, 
and tight junction remodeling. These pathways converged to 
drive productive and nonproductive intussusception, associ-
ated with dramatically increased vesiculation and thickening 
Figure 7. Scheme illustrating the proposed mechanisms underlying mechanisms involved in pathological choriocapillary (CC) remodeling preceding choroidal 
neovascularization (CNV). A, Illustration of healthy, normoxic choriocapillaries. B, Hypoxia-induced pathological CC remodeling is driven by HIF (hypoxia-
induced factor)-1-VEGF (vascular endothelial growth factor)-A-VEGFR2-induced cytoskeletal dynamics/ciliogenesis, vesicle biogenesis, tight junction (TJ), 
and extracellular matrix remodeling pathways, leading to (1) vascular leakage through dissolved TJs (dTJs) and enlarged fenestrations (F), (2) productive and 
nonproductive intussusception including formation of endothelial vesicles (V), increased endothelial thickness (ET), and endothelial luminal projections (ELPs) 
some of which connected to ELPs from the other side of the endothelium leading to immature intussusceptive pillars (imISPs), and (3) splitting of extravas-
cular columns by endothelial processes extending across a column (indicated by white arrowheads) to generate 2 new, smaller columns.
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of the endothelium. Previously, vascular remodeling in the 
choriocapillaris has been found to, in extreme cases, lead to 
occlusion of >90% of the lumen through the formation of 
labyrinth-like vascular structures in wet AMD patients,87 sug-
gesting that luminal occlusion and disruption of blood flow by 
local accumulation of ELPs as shown here, are likely highly 
relevant for and associated with human neovascular disease.
Intussusception has primarily been considered as an alter-
native to sprouting angiogenesis and a mechanism of vascular 
maturation and remodeling of newly developed vascular net-
works.14,17,19,21 Based on the PVR mechanisms presented here, 
we propose that intussusception may also be a vascular prim-
ing step that precedes neovascularization. Intussusception in 
this aspect was characterized by robust EC proliferation and 
degradation of the collagen content in existing extravascular 
columns, followed by column splitting as well as nonproduc-
tive intussusception, that is, the generation of ELPs that to a 
large extent failed to mature into complete ISPs. Several cel-
lular and molecular pathways leading to intussusception and 
formation of mature ISPs have been considered.13,88 In tumors, 
for example, intussusception has been suggested to occur by 
f-actin–mediated pulling of extracellular but EC-associated 
collagen I bundles through the pillar, as it forms.16 Conversely, 
during development, it has been reported that the process is 
facilitated by myofibroblasts pushing through the endothelium 
from the basolateral side towards the lumen, thereby creating 
the pillar.88 In support of a stabilizing role of perivascular myo-
fibroblasts/SMCs, we find that αSMA+/Transgellin+/Pdgfrβ+ 
SMCs are localized at perivascular positions in the choriocap-
illaris, with their cell bodies inside the extravascular columns, 
stretching thin processes across the endothelium presumably as 
a means of providing trophic support. While the SMC invest-
ment was similar in hypoxia-treated fish, the SMC-EC con-
nections were, however, significantly loosened during the PVR 
process. In addition, TEM and immunohistochemistry clearly 
indicated that mature extravascular columns contained col-
lagen I fibers, but that these unlike the SMC content of the col-
umns, are degraded following hypoxia treatment, likely as an 
important step in the vascular fusion/column splitting process. 
The transcriptomic and TEM data presented here also suggests 
that intussusception, at least initially, is an EC-orchestrated 
phenomenon in which the formation of endothelial processes 
from the luminal side drives early pillar formation in a man-
ner that does not involve changes to the basolateral side of the 
endothelium, and therefore is not dependent on perivascular 
collagen I fibers, myofibroblasts or other nonendothelial struc-
tures or cells. Indeed, our data clearly show that the basolateral 
endothelial membrane is smooth and maintain a similar struc-
ture at sites of ELP formation, as at other sites.
The use of zebrafish to understand molecular mechanisms 
involved in vascular pathology and hypoxia benefits not only 
from the fact that pathologically relevant levels of hypoxia can 
be induced by environmental hypoxia treatment as shown in 
this work, but also because HIF-1α knockout zebrafish are vi-
able.57 HIF-1α knockout mice die in utero due to an inhibition 
of developmental angiogenesis.89 Zebrafish embryonic tissues, 
on the contrary, are oxygenated by passive diffusion of ox-
ygen from the water, and developmental angiogenesis is there-
fore not hypoxia- or HIF-1–dependent in this organism.60,90 
This allows embryos to develop in the absence of HIF-1α and 
survive to adulthood. This unique animal model for complete 
lack of HIF-1 signaling57 now provides an opportunity to un-
derstand HIF-1–dependent and independent mechanisms of 
hypoxia-induced PVR and angiogenesis.
VEGFA-VEGFR2 signaling has traditionally been consid-
ered the main mechanism underlying hypoxia-/HIF-1–induced 
vascular responses including angiogenesis and vascular de-
stabilization, whereas VEGFR1 in many cases inhibit angio-
genesis by acting as a VEGF-A scavenger.91 Similarly, PlGF, 
which does not bind to VEGFR2, form heterodimers with 
VEGFA and therefore inhibit VEGFR2-signaling, at least 
when PlGF and VEGFA are produced by the same cell.92 We 
demonstrate that in human choroidal ECs, PlGF, and VEGFR1 
are downregulated in response to hypoxia, whereas VEGF-A 
is dramatically upregulated, findings that were confirmed in 
the zebrafish hypoxia model, suggesting that hypoxia leads 
to a switch towards VEGF-A-VEGFR2 signaling in choroidal 
ECs. This was likely HIF-1α-dependent as we found a com-
plete lack of hypoxia-induced intussusception in HIF-1α-KO 
zebrafish. While in this work we focus on the role of VEGF-
A-VEGFR2 signaling, it is likely that other hypoxia-induced 
factors also play a role during PVR.12,25 In our genome-wide 
analysis of hypoxia-induced changes to the endothelial tran-
scriptome, we find that many receptors for secreted factors 
with potential roles in neovascularization were upregulated in 
ECs from hypoxia-treated zebrafish, although not to a signifi-
cant extent following correction for multiple testing (false dis-
covery rate >0.05). The role of VEGFA-VEGFR2 during PVR 
preceding neovascularization described here does therefore 
not preclude the possibility that other factors could also be 
involved in this process. Indeed, VEGFA-VEGFR2 signaling 
is also important for neovascularization in most other disease 
models including postnatal retinal vascular development93 
and tumor angiogenesis,40,94 but these models are still today 
important and heavily used tools for discovering alternative 
non-VEGF mechanisms, which also play important roles 
in pathological vessel growth. We expect that the zebrafish 
hypoxia-induced pathological choriocapillaris remodeling 
model presented here and now validated in terms of VEGF-
VEGFR2 signaling will similarly prove valuable for identify-
ing and mechanistically linking other factors and targets of 
clinical importance to this process in the future.
In conclusion, we have here demonstrated that patholog-
ical neovascularization is preceded by vascular remodeling, 
which occurs through productive and nonproductive intus-
susception due to VEGF-VEGFR2–induced formation of 
ELPs and increased endothelial fenestration, thickening, ve-
siculation, and disruption of tight junctions. These findings 
shed new light on the process of intussusception, indicating 
that this is initially regulated mainly by luminal endothelial 
sprouting without involvement of basolateral or perivascular 
structures or cells, and suggest a role for intussusception in 
endothelial priming before neovascularization.
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Highlights
• Early pathological vascular remodeling (PVR) and leakage of the choriocapillaris is a vascular priming mechanism associated with age-related 
macular degeneration that can be modeled by hypoxia treatment in adult zebrafish and closely resembles PVR phenotypes in rodents and 
age-related macular degeneration patients.
• PVR involves endothelial cell proliferation, cytoskeletal reorganization, tight junction remodeling, fenestration, vesicle and cilium biogenesis, 
loosening of smooth muscle cell contracts, and degradation of collagen fibers.
• These processes culminate in the production of immature intussusceptive pillars (nonproductive intussusception) as well as both generation 
of new, mature intussusceptive pillars, and splitting of existing extravascular columns (productive intussusception and vessel fusion), which is 
central to the PVR response also in rodents and wet age-related macular degeneration patients.
• PVR is dependent of signaling through the HIF (hypoxia-induced factor)-1-VEGF (vascular endothelial growth factor)-VEGFR2 axis and may be 
targeted using available anti-VEGF approaches.
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